Johnson & Johnson’s US$25.4 B Acquisition of Guidant
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 56 (Table of Contents)
Published: 5 Feb-2005
DOI: 10.3833/pdr.v2005.i56.728 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
The healthcare giant Johnson & Johnson (J&J) is to acquire Guidant, a major player in the growing market for pacemakers and implantable defibrillators for US$25...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS